Market flat despite Teva’s losses

Teva fell heavily following a US court ruling on Copaxone while Perrigo recorded the sharpest rise on the Tel Aviv 25 Index.

Teva 150 (photo credit: REUTERS/Ronen Zvulun)
Teva 150
(photo credit: REUTERS/Ronen Zvulun)
1